Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Merck’s Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?
Merck shares began peeling back in early 2024, mostly on concerns about looming patent expirations for its breadwinning…
Some Georgians could soon be paying double for their medications – WSB-TV Channel 2
ATLANTA — In just a matter of days, President Donald Trump’s pharmaceutical tariff policy will go into effect,…